Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: Emerging Importance for Cancer Treatment and Therapy of Chronic Disease)

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|8|2|77-77

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.8, Iss.2, 2015-08, pp. : 77-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 6-7

Bentham Science Publishers

Access to resources Recommend Favorite

Lutetium-177 Labeled Bombesin Peptides for Radionuclide Therapy

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 33-43

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Combined Cancer Therapy)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6511-6512

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue:Targeting Loss of Tumor Suppressors for Cancer Therapeutics)

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Structure-Function Based Drug Design for Cancer Therapeutics)

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 14, 2016-11 ,pp. : 1200-1200

Bentham Science Publishers

Access to resources Recommend Favorite